03.04.19
1 minute read
The latest issue of Eurosurveillance, Europe’s journal on infectious diseases, features recent research into the prevalence of MRSA among people who inject drugs in “the Bristol clade”.
The study took place between 2012 and 2017 with research partners including Public Health England, National Institute for Health Research, the University of West England and the University of Bristol.
BDP played a significant part in this research project, helping recruit participants through our Needle Exchange located across the city and playing the part of a testing site.
At BDP we are continuing to work towards reducing harm cause by MRSA. We are currently involved in a Design in the Public Sector programme aiming to help local governments and partner organisations use design processes and methods to tackle public health challenges like MRSA.
